Related Experiment Video

Updated: Sep 20, 2026

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
10:02

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

Published on: June 2, 2023

Immunotherapy in fungal allergy

Arthur Helbling1, Andrea Reimers

  • 1Department of Rheumatology and Clinical Immunology/Allergology, University Hospital--Inselspital, 3010 Bern, Switzerland. arthur.helbling@insel.ch

Current Allergy and Asthma Reports
|August 9, 2003
PubMed

Insights

Airborne fungal spores are linked to respiratory allergies and severe asthma. Improved diagnostic tools and recombinant fungal allergens offer new hope for treating fungal allergies.

Area of Science:

  • Allergen immunotherapy
  • Respiratory allergy
  • Fungal allergy

Background:

  • Airborne fungal spores are a known cause of respiratory allergies, particularly severe asthma in young adults.
  • Sensitization rates to fungal allergens can be high (up to 30%) in asthma patients, despite a general prevalence of around 3% in the population.
  • Currently available commercial fungal extracts for diagnosis and therapy are often of poor quality, limiting effective treatment.

Purpose of the Study:

  • To highlight the challenges in diagnosing and treating fungal allergies due to extract quality.
  • To review the efficacy of current immunotherapy for fungal allergies.
  • To explore the potential of recombinant fungal allergens for future diagnosis and immunotherapy.

Main Methods:

  • Review of existing literature on fungal allergy, sensitization, and immunotherapy.
  • Analysis of clinical trial data for immunotherapy efficacy.
  • Discussion of the limitations of current diagnostic and therapeutic approaches.

Main Results:

  • Limited efficacy of immunotherapy has been demonstrated for only two fungal species (Alternaria alternata and Cladosporium herbarum) in controlled trials.
  • The quality of commercial fungal extracts remains a significant barrier to accurate diagnosis and effective treatment.
  • Recombinant fungal allergens present a promising avenue for advancing diagnosis and immunotherapy.

Conclusions:

  • Current methods for diagnosing and treating fungal allergies are suboptimal due to issues with fungal extract quality.
  • Specific immunotherapy has shown promise but is limited to a few fungal species.
  • Recombinant fungal allergens represent a significant advancement for the future of fungal allergy management.

More Related Videos

Intralymphatic Immunotherapy and Vaccination in Mice07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...